Molecular Partners AG (MOLN)
5.08
-0.14
(-2.68%)
USD |
NASDAQ |
Dec 20, 16:00
5.18
+0.10
(+1.97%)
After-Hours: 20:00
Molecular Partners Total Assets (Quarterly): 183.31M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| AC Immune SA | 290.33M |
| CRISPR Therapeutics AG | 2.256B |
| Addex Therapeutics Ltd | 14.46M |
| NLS Pharmaceutics Ltd | 1.194M |
| MoonLake Immunotherapeutics | 518.21M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 18.34M |
| Shareholders Equity (Quarterly) | 164.96M |
| Current Ratio | 14.33 |